AAOA Member Sign In
CME Opportunities

Welcome

Celebrating Over 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

Become A Member

ADVOCACY UPDATES

Congress Considers Extension of Telehealth Flexibilities Post-Pandemic

July 26, 2021

The COVID-19 pandemic forced Congress and the Centers for Medicare & Medicaid Services (CMS) to…

Read more

Changes To E/M Codes Beginning On January 1st

January 7, 2021

Effective January 1, 2021, the Centers for Medicare & Medicaid (CMS) finalized significant changes to…

Read more

Additional COVID-19 Relief Up in the Air

December 8, 2020

House Speaker Nancy Pelosi (D-CA) and Treasury Secretary Steven Mnuchin appeared to be moving closer…

Read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

06/01/23: Research Grant Cycle
Learn more

06/26/23: Membership Application Deadline to be eligible for AAOA Member rate for the 2023 Basic Course

07/01/23: Scientific Abstract Submission Deadline
Learn more

12/01/23: Research Grant Cycle
Learn more

04/01/24: Fellow Exam Application Deadline
Learn more

EDUCATION

2023 AAOA Annual Meeting

Register Now to access over 19 hrs of CME | Continuing Certification through our 2023 Hybrid Annual Meeting. The meeting will take place in Nashville and virtually from September 29 - October 1, 2023. On-Demand post course access will be open until November 14, 2023. Learn More

RESIDENTS

For information about Resident opportunities, DosedDaily, research grants, and other resources. Learn More

IFAR

Available Now

Access For Free

aaoaf-ifar

IFAR Impact Factor: 2.454

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2023 AAOA Annual Meeting - Hybrid
September 29 – October 1, 2023
Embassy Suites by Hilton Nashville Downtown
Learn More and Register

2024 AAOA Advanced Course in Allergy & Immunology - Hybrid
February 8 - 10, 2024
Hyatt Regency Tamaya
Santa Ana Pueblo, New Mexico
(outside Albuquerque)
Learn More and Book Hotel

2024 AAOA Basic Course in Allergy & Immunology - Hybrid
July 25-27, 2024
The Diplomat, Hollywood, Florida
Learn More and Get Hotel Room

2024 AAOA Annual Meeting - Hybrid
November 8-10, 2024
Four Seasons Hotel Las Vegas

USP 797 Online Module
Learn More and Register

AAOA Educational Stacks
Next Availability - November 1, 2023

News and Updates

USP General Chapter Released

November 4, 2022

After a multi-year effort, the long-awaited revision of Chapter 797 Standards for Sterile Compounding (797) of…

Read more

Sore Throat Becoming Dominant COVID Symptom

October 11, 2022

You are encouraged to remain vigilant when any symptoms of URI emerge, especially as COVID…

Read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PARTNER RESOURCE CENTER

AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.

Visit the New Center>

PATIENT CORNER

Hypoallergenic Pet Food: Myth or Magic Solution?

By Alfred Sassler, DO, AAOA PPR Commitee A major pet food producer is marketing a “groundbreaking” cat food to reduce cat allergens. It was released…

(202) 955-5010 contact@aaoallergy.org

Health Professionals

health-pro

Useful Links

News and Alerts

Important Information

Ingestion Update

Previously ingestion challenge testing for food, drugs or other substance was reported under Code 95075. That code has been deleted and effective January 1, 2013 is replaced by two new codes 95076 and 95079. Read More

FDA Updates

The U.S. Food and Drug Administration (FDA) recently approved the following sublingual tablets for pollen-induced allergies.
Read More

Opinions and Comments from the AAOA Leadership

Updated Comments and Opinions

AAOA’s leadership is constantly being called upon to provide input and answer questions about otolaryngology and the treatment of allergic patients. Read More

Useful Resources

<!–

Updated Comments and Opinion

–>

Macra 101 Image

Medicare and MACRA

Medicare has changed its documentation requirements. Read More

NEWS

Practice Management

Many otolaryngologists and their practice administrators confuse marketing and advertising, thinking marketing is limited to advertising to attract new patients.
Learn More

IFAR Article

Topical Budesonide Treatment

The aim of this study was to determine the impact of long-term topical budesonide treatment via the mucosal atomization device (MAD) on the hypothalamic-pituitary-adrenal axis (HPAA) and intraocular pressure (IOP). Read More

Register for Current CME

AAOA Educational Stacks

2023 AAOA Advanced Course in Allergy & Immunology
March 30 – April 1, 2023
The Hythe Vail
Formerly the Vail Marriott Mountain Resort
Learn More and Register

2023 AAOA Basic Course in Allergy & Immunology
June 29 – July 1, 2023
Hyatt Regency Seattle
Learn More and Register

2023 AAOA Annual Meeting
September 29 – October 1, 2023
Embassy Suites by Hilton Nashville Downtown
Learn More and Register

USP 797 Online Module
Learn More and Register

Back To Top